Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean-Reference-Cited by-同舟云学术

Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean

Published:2022-01-21 Issue:3 Volume:101 Page:e28624
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Yamamoto-Furusho Jesús K.,Parra-Holguín Norma N.,Juliao-Baños Fabián,Puentes Fabián,López Rocio,Bosques-Padilla Francisco,Torres Esther A.,Nieves-Jimenéz Humberto,Veitia-Velásquez Guillermo R.,Jara-Alba Maria L.,Bautista Sócrates,Piñol-Jimenez Felipe N.,Salgado-Rosado Pablo,Villa-Ovalles Keyla C.,Abreu-Martinez Yudelka A.,Borges Zunilda,Davila-Bedoya Santiago,Otoya-Moreno Guillermo,Iadé-Vergara Beatriz

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference33 articles.

1. Inflammatory bowel disease: updates on molecular targets for biologics;Katsanos;Gut Liver,2017

2. Progression of inflammatory bowel diseases throughout Latin America and the Caribbean: a systematic review;Kotze;Clin Gastroenterol Hepatol,2020

3. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific;Ng;Am J Gastroenterol,2019

4. Inflammatory bowel disease: an expanding global health problem;M’Koma;Clin Med Insights Gastroenterol,2013

5. Changing global epidemiology of inflammatory bowel diseases: sustaining healthcare delivery into the 21st century;Ananthakrishnan;Clin Gastroenterol Hepatol,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study;Gastroenterología y Hepatología;2024-01

2. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study;Gastroenterología y Hepatología (English Edition);2024-01

3. Risk factors for major complications after surgical treatment of primary ileocecal Crohn's disease. A multicenter Latin American experience;Cirugía Española;2023-12

4. Risk factors for major complications after surgical treatment of primary ileocecal Crohn’s disease. A multicentric Latin American experience;Cirugía Española (English Edition);2023-12

5. Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease;PLOS ONE;2023-11-03